In a large cohort of postmenopausal women, calcium and vitamin D (CaD) supplementation had no effect on incidence of atrial fibrillation (AF), a recent study found. Researchers performed a secondary analysis of the Women’s Health Initiative (WHI) trial on CaD supplementation vs placebo to determine its efficacy for AF prevention. They found:
- Among 16,801 WHI participants, there were 1,453 (8.6%) cases of incident AF over an average of 4.5 years, at an average rate of 19.9 events per 1,000 person-years.
- There was no significant difference in incident AF rates between the CaD and placebo arms.
- After multivariate adjustment, there was no significant association between baseline 25-hydroxyvitamin D serum levels and incident AF.
Boursiquot BC, Larson JC, Shalash OA, et al. Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women. [Published online ahead of print December 13, 2018]. Am Heart J. doi:10.1016/j.ahj.2018.12.006.
This Week's Must Reads
CVD Event Rates Among Adults with PCSK9 Inhibition, Cardiovasc Drugs Ther; ePub 2019 Feb 11; Colantonio, et al
Statin Adherence & Mortality in Patients with ASCVD, JAMA Cardiol; ePub 2019 Feb 13; Rodriguez, et al
Physician Monitoring & LDL-C Follow-Up Testing , Prev Med; 2019 Apr; Dansinger, Williams, et al
CVD Prevalence in HeFH After Statin Treatment, Atherosclerosis; ePub 2019 Feb 12; Perez-Calahorra, et al
Must Reads in Arrhythmias & EP
Frailty & Cognitive Impairment in AF, Am Heart J; ePub 2019 Jan 30; Madhavan, et al
Adherence to Stroke Prevention Therapy for AF, Circulation; ePub 2019 Jan 31; Piccini, et al
Sudden Cardiac Death Risk in the US, Am J Cardiol; ePub 2019 Jan 24; Olson, et al
Thyroid Function Genetic Predictors and AF, JAMA Cardiol; ePub 2019 Jan 23; Salem, et al